FDA.reportPublic FDA data

Cardizem LA 360 MG 24 HR Extended Release Oral Tablet

RxCUI
830898
RxNorm name
Cardizem LA 360 MG 24 HR Extended Release Oral Tablet
Display name
Cardizem LA 360 MG 24 HR Extended Release Oral Tablet
Full name
Cardizem LA 360 MG 24 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Cardizem LADILTIAZEM HYDROCHLORIDEBausch Health US LLC3e180dc7-c871-4efc-8755-cae882976c8d2025-11-11Warnings, Adverse reactionsExact identifier
rxcui: 830898

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3e180dc7-c871-4efc-8755-cae882976c8dCARDIZEM LA 360 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR diltiazem hydrochloride 360 MG Extended Release Oral Tablet [Cardizem] [SBD] · 24 HR Cardizem 360 MG Extended Release Oral Tablet [SY] · Cardizem LA 360 MG 24 HR Extended Release Oral Tablet [SY]419These highlights do not include all the information needed to use CARDIZEM LA safely and effectively. See full prescribing information for CARDIZEM LA. CARDIZEM® LA (diltiazem hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 198220251111